Skip to main content

Table 1 Study population characteristics by frailty status

From: Impact of frailty on the performance of the National Early Warning Score 2 to predict poor outcome in patients hospitalised due to COVID-19

 

Without frailty (CFS < 4)

n = 342

With frailty (CFS ≥ 4)

n = 70

Age, years

53.0 (45.0–65.0)

81.0 (77.0–88.0)

Male sex, n (%)

218 (63.7%)

35 (50.0%)

Body mass index, (kg/m2)

26.6 (24.1–29.9)

24.1 (21.5–27.8)

Charlson Comorbidity Index

1.0 (0.0–3.0)

6.0 (5.0–7.0)

Hypertension, n (%)

67 (19.6%)

33 (47.1%)

Diabetes mellitus, n (%)

48 (14.0%)

19 (27.1%)

Cardiac conditions, n (%)

32 (9.4%)

31 (44.3%)

Chronic kidney disease, n (%)

4 (1.2%)

18 (25.7%)

COPD, n (%)

10 (2.9%)

15 (21.4%)

Asthma, n (%)

39 (11.4%)

5 (7.1%)

Malignancy, n (%)

16 (4.7%)

14 (20.0%)

Current or previous smoking, n (%)

96 (28.7%)

28 (40.6%)

  1. Values are median (interquartile range) or numbers (percentages). CFS indicates Clinical Frailty Scale; COPD Chronic obstructive pulmonary disease. There were 47 missing values for body mass index and 8 for smoking status